ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,247Medicare Part D Prescriptions Filled, Including Refills

Rank: 327 out of 6645

$1.06M Total Retail Price of All Prescriptions

Rank: 280 out of 6645

637 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 14,742 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,211 1,160 1 1
AMLODIPINE BESYLATE 1,186 1,151 2 2
ALENDRONATE SODIUM 876 870 3 14
ATENOLOL 857 832 4 8
LOSARTAN POTASSIUM 758 732 5 12
DIOVAN 524 524 6 19
GLIPIZIDE 468 454 7 23
TRIAMCINOLONE ACETONIDE 462 440 8 55
PRAVASTATIN SODIUM 461 437 9 20
OMEPRAZOLE 450 426 10 6
VOLTAREN 389 386 11 108
HYDROCHLOROTHIAZIDE 339 322 12 9
FAMOTIDINE 275 272 13 33
COMBIVENT 266 266 14 174
BOOSTRIX 253 249 15 456
METFORMIN HCL 229 223 16 7
NAPHAZOLINE HCL 229 216 16 215
PATANOL 201 188 18 131
ACARBOSE 200 193 19 211
LIDODERM 197 192 20 53
SINGULAIR 192 188 21 76
LEVOTHYROXINE SODIUM 191 183 22 4
JANUVIA 187 175 23 38
ATORVASTATIN CALCIUM 176 176 24 10
LOSARTAN-HYDROCHLOROTHIAZIDE 164 154 25 62
FLUOCINONIDE 143 140 26 130
FLUTICASONE PROPIONATE 135 119 27 26
HYDROXYZINE HCL 134 132 R 28 161
DIOVAN HCT 126 126 29 64
ALLOPURINOL 126 126 29 31
METOPROLOL TARTRATE 122 114 31 13
LIPITOR 120 118 32 69
TAMSULOSIN HCL 109 109 33 22
CARVEDILOL 94 94 34 25
NIFEDICAL XL 85 85 35 295
HYDRALAZINE HCL 84 84 36 77
FLOVENT HFA 80 79 37 293
NASONEX 78 78 38 126
POTASSIUM CHLORIDE 78 78 38 28
MONTELUKAST SODIUM 77 77 40 128
GLYBURIDE-METFORMIN HCL 71 65 R 41 95
IBUPROFEN 71 71 41 42
DONEPEZIL HCL 70 70 43 27
FUROSEMIDE 68 68 44 11
GEMFIBROZIL 66 66 45 96
ZOLPIDEM TARTRATE 66 66 45 17
NEXIUM 65 65 47 40
QVAR 65 65 47 103
BENICAR 65 65 47 84
TERAZOSIN HCL 64 63 50 48
GLYBURIDE 63 57 R 51 58
CLOBETASOL PROPIONATE 61 61 52 228
MECLIZINE HCL 59 59 53 122
ENALAPRIL MALEATE 57 57 54 75
PREDNISONE 54 54 55 57
BENAZEPRIL HCL 51 38 56 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.